BARON SILVER STEVENS FINANCIAL ADVISORS, LLC
Position in JNJ — Johnson & Johnson
CIK 1851395
Boca Raton, FL
Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,334,104
+$117,527 QoQ
Shares Held
5,253
+5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#2,709
of 4,664 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARON SILVER STEVENS FINANCIAL ADVISORS, LLC holds $5,410,143 across 7 Drug Manufacturers - General names. JNJ ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
5,253 | $1,334,104 | |
| 2 | LLY |
ELI LILLY & Co
|
775 | $929,558 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,173 | $906,236 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,964 | $894,874 | |
| 5 | PFE |
Pfizer Inc
|
22,560 | $543,244 | |
| 6 | ABBV |
AbbVie Inc.
|
1,986 | $499,757 | |
| 7 | AMGN |
Amgen Inc
|
835 | $302,370 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,334,104 | 5,253 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,216,577 | 4,977 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,168,232 | 5,645 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,038,352 | 5,600 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $865,634 | 5,667 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $905,818 | 5,462 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $792,806 | 5,482 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $900,405 | 5,556 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $815,865 | 5,582 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $915,129 | 5,785 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $853,762 | 5,447 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $905,842 | 5,816 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $931,712 | 5,629 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $799,025 | 5,155 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $927,942 | 5,253 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $1,079,615 | 6,082 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $877,642 | 4,952 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $786,408 | 4,597 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $669,902 | 4,148 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $814,145 | 4,942 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $653,291 | 3,975 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $619,762 | 3,938 | Shares | Sole | 2021-03-19 | |
| No filing history on record for this holder in this stock. | ||||||